These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 912644)
1. Chemotherapy of malignant histiocytosis in adults. Alexander M; Daniels JR Cancer; 1977 Mar; 39(3):1011-7. PubMed ID: 912644 [TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy of malignant histiocytosis. Palazzo E; Bergerat JP; Vetter JM; Boilletot A; Lang JM; Oberling F Acta Haematol; 1979; 62(5-6):251-6. PubMed ID: 95146 [TBL] [Abstract][Full Text] [Related]
3. Chemotherapy of localised histiocytic lymphoma. Miller TP; Jones SE Lancet; 1979 Feb; 1(8112):358-60. PubMed ID: 85006 [TBL] [Abstract][Full Text] [Related]
5. Malignant histiocytosis. Case report and review. Marshall ME J Ky Med Assoc; 1983 Jan; 81(1):18-23. PubMed ID: 6687475 [No Abstract] [Full Text] [Related]
6. Long-term results of patients with advanced diffuse, non-Hodgkin's lymphoma treated with cyclophosphamide, doxorubicin, vincristine, prednisone and bleomycin (CHOP-Bleo). Case DC Oncology; 1983; 40(3):186-91. PubMed ID: 6189041 [TBL] [Abstract][Full Text] [Related]
7. [Experiences in the chemotherapy of malignant histiocytosis]. Herold M; Wutke K; Höche D; Rüdiger KD Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):694-8. PubMed ID: 6172336 [No Abstract] [Full Text] [Related]
8. Combination chemotherapy for acute lymphoblastic leukaemia in adults. Lister TA; Whitehouse JM; Beard ME; Brearley RL; Wrigley PF; Oliver RT; Freeman JE; Woodruff RK; Malpas JS; Paxton AM; Crowther D Br Med J; 1978 Jan; 1(6107):199-203. PubMed ID: 271516 [TBL] [Abstract][Full Text] [Related]
9. Advances in chemotherapy for large cell lymphoma. Coleman M; Gerstein G; Topilow A; Lebowicz J; Berhardt B; Chiarieri D; Silver RT; Pasmantier MW Semin Hematol; 1987 Apr; 24(2 Suppl 1):8-20. PubMed ID: 2438781 [TBL] [Abstract][Full Text] [Related]
10. Chemotherapy of reticuloendotheliosis. Comparison of methotrexate plus prednisone vs. vincristine plus prednisone. Jones B; Kung F; Chevalier L; Forman EN; Rausen A; Koch K; Desposito F; Maurer H; Jacquillat C; Degnan TJ; Pluess H; Desforges J; Patterson RB; Glidewell O; Holland JF Cancer; 1974 Oct; 34(4):1011-7. PubMed ID: 4608879 [No Abstract] [Full Text] [Related]
12. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study. Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501 [TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study. Hoogstraten B; George SL; Samal B; Rivkin SE; Costanzi JJ; Bonnet JD; Thigpen T; Braine H Cancer; 1976 Jul; 38(1):13-20. PubMed ID: 947510 [TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Ravandi F; O'Brien SM; Cortes JE; Thomas DM; Garris R; Faderl S; Burger JA; Rytting ME; Ferrajoli A; Wierda WG; Verstovsek S; Champlin R; Kebriaei P; McCue DA; Huang X; Jabbour E; Garcia-Manero G; Estrov Z; Kantarjian HM Cancer; 2015 Dec; 121(23):4158-64. PubMed ID: 26308885 [TBL] [Abstract][Full Text] [Related]
15. A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project. Smalley RV; Carpenter J; Bartolucci A; Vogel C; Krauss S Cancer; 1977 Aug; 40(2):625-32. PubMed ID: 329975 [TBL] [Abstract][Full Text] [Related]
17. Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology. Canellos GP; Skarin AT; Rosenthal DS; Moloney WC; Frei E Cancer Treat Rep; 1981; 65 Suppl 1():125-9. PubMed ID: 6173118 [TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study. Longo DL; Duffey PL; Gribben JG; Jaffe ES; Curti BD; Gause BL; Janik JE; Braman VM; Esseltine D; Wilson WH; Kaufman D; Wittes RE; Nadler LM; Urba WJ Cancer J; 2000; 6(3):146-50. PubMed ID: 10882329 [TBL] [Abstract][Full Text] [Related]
19. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis. Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406 [TBL] [Abstract][Full Text] [Related]
20. The chemotherapy of lymphoblastic lymphoma. Voakes JB; Jones SE; McKelvey EM Blood; 1981 Jan; 57(1):186-8. PubMed ID: 7448410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]